1235 related articles for article (PubMed ID: 29874105)
1. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the EORTC QLQ-BM22 and the BOMET-QOL quality of life questionnaires in patients with bone metastases.
Bedard G; Zeng L; Poon M; Lam H; Lauzon N; Chow E
Asia Pac J Clin Oncol; 2014 Jun; 10(2):118-23. PubMed ID: 23551978
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Polish version of the EORTC QLQ-BM22 module for the assessment of health-related quality of life in patients with bone metastases.
Püsküllüoğlu M; Tomaszewski KA; Bottomley A; Holden L; Tomaszewska IM; Głowacki R; Bereza K; Golec EB; Chow E; Krzemieniecki K
Qual Life Res; 2014 Mar; 23(2):527-32. PubMed ID: 23912854
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Chinese version of EORTC QLQ-BM22 in patients with bone metastases.
Zhang L; Su YJ; Chen JY; Liao ZC; Luo ZQ; Xie SM; Zhang J; Lin YS; Guo H; Sun WL; Pekbay B; Miller AR; Luo L; Rui YH; Li MH; Wang CL
Support Care Cancer; 2016 Mar; 24(3):1019-24. PubMed ID: 26245496
[TBL] [Abstract][Full Text] [Related]
5. A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy.
Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JS; Dennis K; DeAngelis C; Wong RK; Zhu L; Brundage M
Radiother Oncol; 2016 May; 119(2):208-12. PubMed ID: 27157890
[TBL] [Abstract][Full Text] [Related]
6. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases.
Chow E; Nguyen J; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Bottomley A;
Cancer; 2012 Mar; 118(5):1457-65. PubMed ID: 21837676
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in responders after palliative radiation therapy for painful bone metastases using EORTC QLQ-C30 and EORTC QLQ-BM22: results of a Brazilian cohort.
Mendez LC; Raman S; Wan BA; da Silva JLP; Moraes FY; Lima KMLB; Silva MF; Diz MDPE; Chow E; Marta GN
Ann Palliat Med; 2017 Aug; 6(Suppl 1):S65-S70. PubMed ID: 28595442
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases.
Popovic M; Nguyen J; Chen E; Di Giovanni J; Zeng L; Chow E
Expert Rev Pharmacoecon Outcomes Res; 2012 Apr; 12(2):213-9. PubMed ID: 22458622
[TBL] [Abstract][Full Text] [Related]
9. Translation into Portuguese, cross-cultural adaptation and validation of "The European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire-Bone Metastases-22".
Miki-Rosário N; Garcia Filho RJ; Garcia JG; Dini GM; Bottomley A; Chow E; Sabino Neto M
Ann Palliat Med; 2016 Jul; 5(3):190-5. PubMed ID: 27334351
[TBL] [Abstract][Full Text] [Related]
10. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
Araya LT; Gebretekle GB; Gebremariam GT; Fenta TG
Health Qual Life Outcomes; 2019 Jan; 17(1):13. PubMed ID: 30642359
[TBL] [Abstract][Full Text] [Related]
11. An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases.
Zeng L; Chow E; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Bedard G; Bottomley A
Support Care Cancer; 2012 Dec; 20(12):3307-13. PubMed ID: 22562607
[TBL] [Abstract][Full Text] [Related]
12. [The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire for Japanese patients with bone metastases--The Japanese version of the EORTC QLQ-BM22].
Satoh T; Kobayashi K; Hori T; Iida S; Sato A; Ishiguro H; Chow E; Shimozuma K
Gan To Kagaku Ryoho; 2010 Aug; 37(8):1507-12. PubMed ID: 20716876
[TBL] [Abstract][Full Text] [Related]
13. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22.
Chow E; Hird A; Velikova G; Johnson C; Dewolf L; Bezjak A; Wu J; Shafiq J; Sezer O; Kardamakis D; van der Linden Y; Ma B; Castro M; Arnalot PF; Ahmedzai S; Clemons M; Hoskin P; Yee A; Brundage M; Bottomley A;
Eur J Cancer; 2009 May; 45(7):1146-1152. PubMed ID: 19097882
[TBL] [Abstract][Full Text] [Related]
14. A prospective study to validate the Polish language version of the European Organisation for Research and Treatment of Cancer (EORTC) Colorectal Liver Metastases (QLQ-LMC21) module.
Paradowska D; Bereza K; Sanna B; Kucharska E; Tomaszewska IM; Dudkiewicz Z; Skotnicki P; Bottomley A; Tomaszewski KA
Eur J Oncol Nurs; 2017 Aug; 29():148-154. PubMed ID: 28578847
[TBL] [Abstract][Full Text] [Related]
15. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
16. The Azeri Version of European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30): Translation and Validation.
Davudov MM; Harirchi I; Amiraliyev N; Mehtiyeva E; Mirzajani Z; Amiraliyev K; Rustamli N; Zebardast J; Montazeri A
Asian Pac J Cancer Prev; 2020 Jan; 21(1):267-271. PubMed ID: 31983195
[TBL] [Abstract][Full Text] [Related]
17. The reliability and validity of the Iranian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: the EORTC QLQ-BM22.
Yekaninejad MS; Ahmadzadeh A; Mosavi SH; Saffari M; Pakpour AH; Tolooei F; Chow E; Bottomley A
Expert Rev Pharmacoecon Outcomes Res; 2014 Feb; 14(1):147-56. PubMed ID: 24328844
[TBL] [Abstract][Full Text] [Related]
18. Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22.
Zeng L; Chow E; Bedard G; Zhang L; Fairchild A; Vassiliou V; Alm El-Din MA; Jesus-Garcia R; Kumar A; Forges F; Tseng LM; Hou MF; Chie WC; Bottomley A
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e337-42. PubMed ID: 22763028
[TBL] [Abstract][Full Text] [Related]
19. Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.
Raman S; Ding K; Chow E; Meyer RM; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JSY; Nabid A; Haas R; Wiggenraad R; Babington S; Demas WF; Wilson CF; Wong RKS; Zhu L; Brundage M
Qual Life Res; 2018 Apr; 27(4):1089-1098. PubMed ID: 29188483
[TBL] [Abstract][Full Text] [Related]
20. Design and development of a disease-specific quality of life tool for patients with aplastic anaemia and/or paroxysmal nocturnal haemoglobinuria (QLQ-AA/PNH)-a report on phase III.
Niedeggen C; Singer S; Groth M; Petermann-Meyer A; Röth A; Schrezenmeier H; Höchsmann B; Brümmendorf TH; Panse J
Ann Hematol; 2019 Jul; 98(7):1547-1559. PubMed ID: 31115593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
